Inventor
Robin Smith
Inventor
Palo Alto, CA, US
Overview
Patents· 16 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
H10Pprimary
H10PGeneric processes or apparatus for the manufacture or treatment of devices covered by class h1022%
H10DInorganic electric semiconductor devices14%
H10FInorganic semiconductor devices sensitive to infrared radiation, light, electromagnetic radiation of shorter wavelength or corpuscular radiation14%
Y02EReduction of greenhouse gas [ghg] emissions, related to energy generation, transmission or distribution14%
H01LSemiconductor devices11%
A61NElectrotherapy5%
B82YSpecific uses or applications of nanostructures5%
C30BSingle-crystal growth5%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms3%
H01SDevices using the process of light amplification by stimulated emission of radiation [laser] to amplify or generate light3%
PatentTitleYear
9,236,249'III-N material grown on REN epitaxial buffer on Si substrate'20169,139,934'REN semiconductor layer epitaxially grown on REAIN/REO buffer on Si substrate'20159,105,471'Rare earth oxy-nitride buffered III-N on silicon'20158,878,188'REO gate dielectric for III-N device on Si substrate'20148,748,900'Re-silicide gate electrode for III-N device on Si substrate'20148,542,437'Earth abundant photonic structures'20138,501,635'Modification of REO by subsequent III-N EPI process'20138,394,194'Single crystal reo buffer on amorphous SiOx'20138,178,841'Monolithically integrated IR imaging using rare-earth up conversion materials'20128,049,100'Multijunction rare earth solar cell'20118,039,736'Photovoltaic up conversion and down conversion using rare earths'20118,039,737'Passive rare earth tandem solar cell'20118,039,738'Active rare earth tandem solar cell'20116,575,898'Methods and devices for ex vivo irradiation of autologous coronary bypass conduit'20036,419,625'Methods and devices for ex vivo irradiation of autologous coronary bypass conduit'20025,932,414'Methods and compositions for the monitoring and quantitation of minimal residual disease in hematopoietic tumors'1999Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1999Based in Dallas, TX, US· patent location history
2002–2003Based in Estill Springs, TN, US· patent location history
2011–2016Patents assigned to TRANSLUCENT INC (11)· patent assignee history
2011–2016Patents assigned to CLARK ANDREW (9)· patent assignee history
2011–2016Patents assigned to SMITH ROBIN (9)· patent assignee history
2011–2016Based in Palo Alto, CA, US· patent location history
2011–2012Based in Mountain View, CA, US· patent location history
2013–2016Patents assigned to DARGIS RYTIS (5)· patent assignee history
2013–2016Patents assigned to LEBBY MICHAEL (5)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| TRANSLUCENT INC | 11 | 2011–2016 |
| CLARK ANDREW | 9 | 2011–2016 |
| SMITH ROBINself | 9 | 2011–2016 |
| DARGIS RYTIS | 5 | 2013–2016 |
| LEBBY MICHAEL | 5 | 2013–2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Palo Alto, California, US | 11 | 2011–2016 |
| Mountain View, California, US | 2 | 2011–2012 |
| Estill Springs, TN, US | 2 | 2002–2003 |
| Dallas, Texas, US | 1 | 1999 |